Research and development of products in the segment of living poultry vaccines (Q2727901): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string)
(‎Changed label, description and/or aliases in fr: translated_label)
label / frlabel / fr
 
Recherche et développement de produits dans le segment des vaccins vivants contre la volaille

Revision as of 09:45, 26 November 2021

Project Q2727901 in Croatia
Language Label Description Also known as
English
Research and development of products in the segment of living poultry vaccines
Project Q2727901 in Croatia

    Statements

    0 references
    11,658,803.09 Croatian kuna
    0 references
    1,515,644.4 Euro
    2 June 2021
    0 references
    28,223,776.27 Croatian kuna
    0 references
    3,669,090.92 Euro
    2 June 2021
    0 references
    85.0 percent
    0 references
    19 April 2018
    0 references
    12 June 2021
    0 references
    Genera dioničko društvo za razvoj i proizvodnju farmaceutskih proizvoda
    0 references
    0 references

    45°47'48.26"N, 15°46'34.64"E
    0 references
    10431
    0 references
    Svrha projekta je podići globalnu konkurentnost Genera d.d. razvojem i plasmanom inovativnog veterinarsko-medicinskog proizvoda - novog programa živih (atenuiranih) liofiliziranih cjepiva od četiri cjepna soja, za kombiniranu primjenu i sinergistički efekt prlikom tretiranja infektivnog bronhitisa i zarazne bolesti burze u peradi, kao i jačanjem istraživačko-razvojnih kapaciteta tvrtke. (Croatian)
    0 references
    The project aims to strengthen the global competitiveness of Genera d.d. through the development and placement of innovative veterinary medicinal products — new alive (attenuated) lyophilised vaccines of four vaccine vaccinated strains, for the combined use and synergistic effect of infective bronchitis and contagious animal exchange diseases, as well as by strengthening the company’s research and development research and development capacity. (English)
    3 June 2021
    0 references

    Identifiers

    KK.01.2.1.01.0092
    0 references